etherna is attending the Advanced Therapies conference in Barcelona from September 7-9, 2026, with Bram Bogaert attending.

Driving discovery and solving challenges for partners across nucleic acid–based medicine, spanning LNP formulation and RNA chemistry | www.etherna.be We are a nucleic acid–based medicine technology platform company, partnering with pharma and biotech industry players with an emerging or established interest in nucleic acid therapeutics. Our expert team supports start‑up, early‑stage, and late‑stage projects by using our proprietary platforms across RNA chemistry, LNP formulation, and process technologies to drive new pipeline development or resolve manufacturing challenges for our partners.